Clinical trial · Observational
Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma
Recurrence ad Survival After Robotic Versus Laparoscopic Liver Resection in Very-early to Early (BCLC 0-A) Hepatocellular Carcinoma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of the study is to investigate the long-term outcomes of minimally invasive liver surgery (robotic vs laparoscopic) for hepatocellular carcinoma patients of stage BCLC 0-A. Data from two tertiary centers for liver surgery will be retrospectively reviewed. Patients will be divided in two cohorts (robot; laparoscopy). The primary endpoint will be recurrence-free and overall survival; secondary endpoints were incidence, pattern, and treatment of recurrences.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Minimally invasive liver resection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Robotic liver resections
- interventionNames
- Procedure: Minimally invasive liver resection
- label
- Laparoscopic liver resection
- interventionNames
- Procedure: Minimally invasive liver resection
Primary outcomes (2)
- measure
- Recurrence-free survival
- timeFrame
- From the date of liver resection until the first documented HCC progression on follow-up imaging, assessed up to 116 months. The Minimum follow-up accepted was of 3 months postoperatively.
- description
- Recurrence was dated at the first HCC detection on follow-up imaging.
- measure
- Overall survival
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients undergoing robotic and laparoscopic resections * Histology-confirmed HCC of stage BCLC 0-A * Preserved liver function (Child score A-B) * Patients \>18 years old Exclusion Criteria: * Hand-assisted procedures * Non-elective surgery * Intraoperative switch to locoregional therapies (like radiofrequency or microwave ablation) * Non-histologically confirmed HCC * Mixed hepato-cholangiocarcinoma.
References
Publications (0)
Data not yet available